Senior Scientist, Head of the Department of Cytogenetics and Genomics,
Professor, CING Postgraduate School
BSc, Biology, Stockholm University, Sweden
PhD, Molecular Genetics, Nottingham University, UK
Dr. Sismani obtained her PhD in Genetics from the University of Nottingham, in UK in 2004. She was employed at the Department of Cytogenetics and Genomics of the Cyprus Institute of Neurology and Genetics (CING) in 1995, became a Scientist in 2005 and appointed as Senior Scientist and Head of the Department in 2012. The Department offers diagnostic services, research and educational programs and also has double accreditation from the College of American Pathologists and with ISO 15189. She currently also holds the position of Professor and she is the Coordinator of the Medical Genetics program and the course of Cytogenetics and Genomics at the postgraduate school of CING. In addition, she is training many Scientists in the field of Cytogenetics and Genomics.
Dr Sismani performs cytogenetic and molecular diagnostic services for preimplantation, prenatal and postnatal diagnosis of chromosomal abnormalities as well as many other genetic diseases and syndromes that cause intellectual disability, malformations (post and prenatal), infertility and other conditions. The genetic investigation and mechanism of formation of these conditions are also the focus of Dr. Sismani's research activities with the ultimate goal of improving the quality of life of patients. She has received a number of national and European grants either the Principal or co-Principal Investigator She has also supervised more than 35 master's and doctoral students . She has published over 85 papers in international peer review journals, 5 book chapters and more than 130 abstracts in poster or oral form in International conferences. Dr. Sismani has successfully organized national and international conferences and educational seminars. She has also served on several national board committees and she also a member of the Cyprus Medically Assisted Reproduction Council and an Assessor at the EMQN (European Molecular Genetics Quality Network) for Fragile X Syndrome.
Selected Publications